MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/joa3.13114

Медицинская библиотека · Journal of arrhythmia · 2024

Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.

Accioli Riccardo, Lazzerini Pietro Enea, Salvini Viola, Cartocci Alessandra, Verrengia Decoroso, Marzotti Tommaso, Salvadori Fabio, Bisogno Stefania, Cevenini Gabriele, Voglino Michele, Gallo Severino, Pacini Sabrina, Pazzaglia Martina, Tansini Angelica, Otranto Ambra, Laghi-Pasini Franco, Acampa Maurizio, Boutjdir Mohamed, Capecchi Pier Leopoldo

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Severely ill patients with coronavirus disease 2019 (COVID-19) show an increased risk of new-onset atrioventricular blocks (AVBs), associated with high rates of short-term mortality. Recent data suggest that the uncontrolled inflammatory activation observed in these patients, specifically interleukin (IL)-6 elevation, may play an important pathogenic role by directly affecting cardiac electrophysiology. The aim of our study was to assess the acute impact of IL-6 changes on electrocardiographic indices of atrioventricular conduction in severe COVID-19.

METHODS

We investigated (1) the behavior of PR-interval and PR-segment in patients with severe COVID-19 during active phase and recovery, and (2) their association with circulating IL-6 levels over time.

RESULTS

During active disease, COVID-19 patients showed a significant increase of PR-interval and PR-segment. Such atrioventricular delay was transient as these parameters rapidly normalized during recovery. PR-indices significantly correlated with circulating IL-6 levels over time. All these changes and correlations persisted also in the absence of laboratory signs of cardiac strain/injury or concomitant treatment with PR-prolonging drugs, repurposed or not.

CONCLUSIONS

Our study provides evidence that in patients with severe COVID-19 and high-grade systemic inflammation, IL-6 elevation is associated with a significant delay of atrioventricular conduction, independent of concomitant confounding factors. While transient, such alterations may enhance the risk of severe AVB and associated short-term mortality. Our data provide further support to current anti-inflammatory strategies for severe COVID-19, including IL-6 antagonists.

Для цитирования: Accioli Riccardo, Lazzerini Pietro Enea, Salvini Viola, Cartocci Alessandra, Verrengia Decoroso, Marzotti Tommaso, Salvadori Fabio, Bisogno Stefania, Cevenini Gabriele, Voglino Michele, Gallo Severino, Pacini Sabrina, Pazzaglia Martina, Tansini Angelica, Otranto Ambra, Laghi-Pasini Franco, Acampa Maurizio, Boutjdir Mohamed, Capecchi Pier Leopoldo. Increased interleukin-6 levels are associated with atrioventricular conduction delay in severe COVID-19 patients.. Journal of arrhythmia. 2024. DOI: 10.1002/joa3.13114.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.